IDH1 and central nervous system cancer: Given the minimal number of IDH1 mutant tumor samples in the TCGA dataset, Cooper et al. examined and confirmed the expression of this proneural signature in lower grade gliomas, which are known to be highly enriched for IDH1 mutations5,10.